robertjsenese
Guest
Good morning,
The clinical laboratory process is: when they receive a UDT,
1.) run it through an analyzer for a +/- result on 13 drugs (and validity)
2.) take the specimen and then run it through a Mass Spec for definitive result on drugs that are abused but not recognized on the analyzer (i.e. synthetic cannaboids, alcohol metabolites, etc.)
My question then is, is it acceptable to bill for the presumptive/qualatitive screen,
with G0431/80301
and then bill for the definitive profile from the confirmation test.
or should be only be billing for the confirmation.
thank you.
The clinical laboratory process is: when they receive a UDT,
1.) run it through an analyzer for a +/- result on 13 drugs (and validity)
2.) take the specimen and then run it through a Mass Spec for definitive result on drugs that are abused but not recognized on the analyzer (i.e. synthetic cannaboids, alcohol metabolites, etc.)
My question then is, is it acceptable to bill for the presumptive/qualatitive screen,
with G0431/80301
and then bill for the definitive profile from the confirmation test.
or should be only be billing for the confirmation.
thank you.